Palette Life Sciences is a fully-integrated medical device company focused on providing a wide range of products and services that improve the quality of life for patients. Led by experienced healthcare executives, the initial company strategy is to transform applications of existing technologies to bring forward novel solutions for underserved conditions. Our portfolio of products focuses on treating conditions in urology/urogynecology disorders, colorectal conditions, radiotherapy, and interventional oncology procedures.
We are a passionate team of individuals who enjoy the thrill of building a company whose culture is one of curiosity, compassion and drive. Looking for like-minded staff that has a complementary experience to add to the team. Our superior benefits package is proof positive that we care about our people.
Deflux® - the only FDA-approved injectable treatment of vesicoureteral reflux (VUR), a malformation of the urinary bladder that affects 1% of children worldwide. VUR can cause severe infections of the urinary tract and lead to irreversible kidney damage.
Solesta® - the only FDA-approved injectable treatment for fecal incontinence, which is also cleared for commercialization in Europe. Fecal incontinence is a debilitating health problem afflicting about 2% of people worldwide with four times more prevalent in women than men.
Barrigel®* - a biodegradable injectable treatment for protection of the rectal wall when treating prostate cancer with radiation. The product is approved in Europe and will be further developed for future market introduction in the US.
Palette Life Sciences is headquartered in Stockholm, Sweden, with offices in Santa Barbara, California and Dallas, Texas. Learn more at palettelifesciences.com and pharmanest.se.
Deflux®, Solesta®, Barrigel®, Restylane®, and NASHA™ are registered trademarks.
*In the US, this product is considered investigational and not available for commercial sale in the US.
Location: Sweden, Stockholm
Employees: 51-200
Total raised: $40M
Founded date: 2018
Investors 1
Date | Name | Website |
30.08.2023 | OrbiMed | orbimed.co... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
21.10.2021 | - | $40M | - | marketscre... |
Mentions in press and media 21
Date | Title | Description | Source |
30.05.2023 | Palette Life Sciences Welcomes New Barrigel® Center of Excel... | /EIN News/ -- Recognizing exceptional leadership in patient education and clinical skill in the Barr... | einpresswi... |
09.02.2023 | Palette Life Sciences tillkännager publicering av Barrigel® ... | Den pivotala studien visar att separation av rektum och prostatan med Barrigel® är säkert och effekt... | einpresswi... |
09.02.2023 | Palette Life Sciences Announces Publication of Barrigel® Piv... | Rectal spacing with Barrigel® is proven safe and effective in improving rectal dosimetry and reducin... | einpresswi... |
09.06.2022 | Palette Life Sciences tillkännager FDA godkännande av Barrig... | Banbrytande teknologi minskar risken för strålskador i ändtarmen – bättre kontroll och optimerad lok... | globenewsw... |
09.06.2022 | Palette Life Sciences Announces FDA 510(k) Clearance for Bar... | SANTA BARBARA, Calif. and STOCKHOLM, Sweden, June 09, 2022 (GLOBE NEWSWIRE) -- Palette Life Sciences... | globenewsw... |
29.03.2022 | Palette Life Sciences Receives Favorable Post Approval Study... | SANTA BARBARA, Calif. and STOCKHOLM, Sweden, March 29, 2022 (GLOBE NEWSWIRE) -- Palette Life Science... | globenewsw... |
24.02.2022 | Palette Life Sciences inleder ett samarbete med Lantheus för... | SANTA BARBARA, Calif. och STOCKHOLM, Sverige, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Palette Life Science... | globenewsw... |
24.02.2022 | Palette Life Sciences Enters Into an Agreement with Lantheus... | Partnership leverages Palette’s specialty sales team to increase promotional footprint of PYLARIFY w... | globenewsw... |
15.02.2022 | Palette Life Sciences Announces the Establishment of a Wholl... | Expansion will allow for Palette Life Sciences to provide better support to healthcare providers in ... | globenewsw... |
15.02.2022 | Palette Life Sciences tillkännager bildandet av ett helägt d... | Utvidgningen kommer att göra det möjligt för Palette Life Sciences att ge bättre stöd till vårdgivar... | globenewsw... |
Show more